Regulation
Mississippi Pension Sues Mylan over Alleged Scheme to Deceive FDA
President Rajiv Malik is accused of ordering workers to manipulate quality control data.
Pension wants firm to recoup incentive compensation from execs who behave badly.
A recently filed form reveals the EpiPen company ignored majority shareowner votes again, and the response is ferocious.
Although shareholders voted against Management Proposal 5, the directors remain.
Four pension funds say the drug maker has “reached new lows in corporate stewardship.”